Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The co-primary endpoints were change in desire (measured by the Female Sexual Function Index desire domain) and change in distress (measured by the Female Sexual Distress Scale-Desire/Arousal/Orgasm)
Quick Stats for GLP-1 Diabetes Treatment Drugs Market GLP-1 Diabetes Treatment Drugs Market Value (2025): USD 6,556.5 million GLP-1 Diabetes Treatment Drugs Market Forecast Value (2035): USD 62,543.2 million GLP-1 Diabetes Treatment Drugs Market Forecast CAGR: 25.3% Leading Drug Type in GLP-1 Diabetes Treatment Drugs Market: Liraglutide (35.5%) Key Growth Regions in GLP-1 Diabetes Treatment Drugs Market: Asia Pacific, North America, and Europe Top Key Players in GLP-1 Diabetes Treatment Drugs Market: Eli Lilly, Sanofi, Novo Nordisk, Hanmi Pharmaceutical Co., Boehringer Ingelheim, AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline (GSK), Ganli Pharmaceuticals, Tonghua Dongbao, Shanghai Renhui Biopharmaceuticals Co., Ltd., Huadong Medicine, Page Biopharmaceuticals, Jiangsu Hausen Pharmaceuticals Group Co., Ltd
Plus, considering the other studies weve seen and referenced on phosphates, we can confidently say that Siliphos has the potential to improve absorption and bioavailability
ArticlePubMed 23
US$ 21.08
US$ 24.09
US$ 24.61
